Dr. Zak's / Grenade B2B Profile: Growth Trajectory and Partnership Potential

United Kingdom — 27 July 2026

Dr. Zak's, now largely overshadowed by its acquired counterpart, Grenade, represents a foundational chapter in the functional food segment. Grenade, under the ownership of Mondelēz International, has evolved into a significant player in the ‘better-for-you’ snacking market, blurring the lines between traditional confectionery and sports nutrition. Its trajectory illustrates the increasing mainstream appeal of protein-fortified products and the commercial imperative for supplement brands to broaden their retail footprint beyond specialist channels.

Company Snapshot

Grenade's primary operations are based in the UK. While specific standalone revenue figures post-acquisition are not publicly disclosed by Mondelēz, industry estimates place Grenade's annual turnover in the region of £60-70 million at the time of its acquisition. Key products include the Carb Killa protein bar range, protein shakes, and various functional snacks. The brand maintains a presence in over 50 markets globally, with significant footholds in Europe, North America, and Australia. Employee numbers are estimated to be in the range of 100-200, integrated within Mondelēz's broader corporate structure.

Strategic Position and Recent Moves

Grenade's strategic position is defined by its 2021 acquisition by Mondelēz International for an undisclosed sum, estimated by market analysts to be in the region of £200 million. This move cemented Grenade's transition from a niche sports nutrition brand to a mainstream functional snack provider, leveraging Mondelēz's vast distribution network and marketing capabilities. Recent product launches have focused on expanding the Carb Killa range with new flavours and formats, such as Carb Killa Go Nuts and Carb Killa Spread. In the last 12 months, Grenade has also pushed further into the ready-to-drink protein shake market, directly competing with brands like Optimum Nutrition and Myprotein within convenience and grocery channels. This expansion reflects a deliberate strategy to capture market share from traditional confectionery and mainstream snack categories, capitalising on consumer demand for perceived healthier alternatives. The brand has also been visible through partnerships with major retailers and fitness influencers, reinforcing its lifestyle positioning.

What Manufacturers Can Learn

Grenade's success under Mondelēz highlights the commercial viability of 'snackification' within the supplement industry. Contract manufacturers and ingredient suppliers should recognise the growing demand for palatable, convenient, and mass-market functional food formats. Focus should be placed on developing innovative texture and flavour solutions that mask the organoleptic challenges of high-protein formulations. The ability to produce at scale, maintain consistent quality, and meet stringent food safety standards for major retail distribution is paramount. As one industry analyst commented, "Grenade proves that the future of many supplements isn't a capsule, it's a mainstream snack bar with a functional twist. Manufacturers need to adapt their R&D and production capabilities accordingly." Ingredient suppliers should also note the shift towards ingredients that offer both nutritional benefits and improved sensory profiles, moving beyond basic protein isolates.

Risks and Headwinds

Despite its strong market position, Grenade faces several risks. Regulatory scrutiny over health claims for functional foods remains a constant challenge, particularly regarding sugar content in some products, which can undermine the 'healthy' perception. Intense competition from both established confectionery giants entering the functional space (e.g., Mars Protein) and agile start-ups continually innovating in the 'better-for-you' sector poses a threat. Pricing pressure in mainstream retail channels could also impact margins. Furthermore, the brand's reliance on a relatively narrow product portfolio, primarily the Carb Killa bar, makes it vulnerable to shifts in consumer preferences or the emergence of disruptive product formats. As another industry observer noted, "While the Mondelēz backing is immense, Grenade must continue to innovate rigorously to avoid becoming a one-hit wonder in a rapidly evolving market."

The B2B Verdict

Supplement businesses should actively watch Grenade. Its trajectory offers a clear blueprint for mainstream market penetration and the snackification of functional ingredients. Partnering with Grenade or similar brands could offer significant co-manufacturing or ingredient supply opportunities, particularly for those capable of high-volume, high-quality production. Competing directly in the mainstream functional snack arena requires substantial capital and distribution leverage, making direct competition challenging for smaller players. The takeaway is clear: understand convenience, taste, and accessibility are now as critical as efficacy.